respiratory

News

Nebuliser being filled. Copyright Vectura (002)

Vectura agrees $1.4bn takeover by private equity group Carly...

Vectura has agreed to a £1.55 per share takeover by US private investment company Carlyle, which values the UK drug delivery specialist at £958 million ($1.4 billion).

News

FDA extends tie-up with CN Bio to test 'lung-on-a-chip' tech

The FDA has extended a collaboration with the UK firm CN Bio to investigate a “lung-on-a-chip” model to investigate inhaled drugs.

News

UK data hub to apply AI to health records for COVID-19 and r...

Health Data Research UK’s respiratory hub BREATHE is set to use artificial intelligence (AI) to unlock real-world insights from electronic health records (EHRs) as part of a new partnership

News

COVID cough app Hyfe launches in UK and Ireland

A smartphone app that uses artificial intelligence to assess the sound of coughing has been launched in the UK, and according to its developer could be an early warning system for COVID-19

News

AstraZeneca breathes sigh of relief as court blocks US Symbi...

A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper competition for the ageing blockbuster.

News

AZ trumpets tezepelumab data as filing for severe asthma loo...

AstraZeneca says full data from the NAVIGATOR trial of tezepelumab in severe asthma keep it on course to file for approval in the first half of this year, with a broader indication than riv

Vectura agrees $1.4bn takeover by private equity group Carly...

FDA extends tie-up with CN Bio to test 'lung-on-a-chip' tech

UK data hub to apply AI to health records for COVID-19 and r...

COVID cough app Hyfe launches in UK and Ireland

AstraZeneca breathes sigh of relief as court blocks US Symbi...

AZ trumpets tezepelumab data as filing for severe asthma loo...

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

respiratory

Editor's Picks